News and Reports
-
Monte Rosa Therapeutics Announces Strategic Collaboration with Roche to Discover Novel Molecular Glue Degraders Targeting Cancer and Neurological Diseases
17 October 2023Download -
Monte Rosa Therapeutics Announces Interim PK/PD and Clinical Data for MRT-2359 in Phase 1/2 Trial for MYC-Driven Solid Tumors
17 October 2023Download -
eGenesis Announces Publication in Nature of Landmark Preclinical Data Demonstrating Long-Term Survival with Genetically Engineered Porcine Kidneys
11 October 2023Download -
Karius Test® Improves the Diagnosis and Management of Pneumonia in Patients Undergoing Treatment for Blood Cancer
10 October 2023Download -
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
25 September 2023Download -
Swixx Biopharma Expands to Mena Region, Appoints Manar Al Nahar as Regional General Manager, Mena
18 September 2023Download -
Boditech Med and SphingoTec close Market Development Agreement to Boost Commercialization of Kidney Function Biomarker PenKid
31 August 2023Download -
FORE Biotherapeutics Announces $75M in Series D Financing and CEO Transition
23 August 2023Download -
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
9 August 2023Download -
Upstream Bio Announces $200M Series B Financing to Advance UPB-101 for Allergic and Inflammatory Diseases
8 June 2023Download -
Upstream Bio Presents New Phase 1 Clinical Data on UPB-101 at the American Thoracic Society (ATS) International Conference
22 May 2023Download -
Numab Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of NM26 Program
15 May 2023Download -
Swixx and Beigene Partner in 13 Countries of Central and Eastern Europe, Greece, Cyprus and Malta
9 May 2023Download -
SphingoTec's Innovative IVD Product sphingotest® penKid® Receives First IVDR Certificate
9 May 2023Download -
Antiva Biosciences Closes $53 Million Series E Equity Financing Led by MPM-BioImpact Capital and Names Kristine Ball President and CEO
27 April 2023Download -
Sai Life Sciences opens SSRL, a dedicated research facility for Schrödinger, at its Hyderabad R&D Campus
20 April 2023Download -
ArriVent Biopharma Closes $155 Million Oversubscribed Series B Financing
27 March 2023Download -
Mineralys Therapeutics Announces Pricing of Upsized Initial Public Offering
9 February 2023Download -
Neuron23 Announces First-in-Human Dose in Phase 1 Clinical Trial of its Best-in-Class Brain-Penetrant LRRK2 Inhibitor for Parkinson’s Disease
7 February 2023Download -
SWIXX and BioCryst partner for ORLADEYO® (berotralstat) in Central and Eastern Europe
24 January 2023Download -
SWIXX and Jazz Pharmaceuticals expand partnership with agreement to now distribute EPIDYOLEX® (CANNABIDIOL) in CEE territory
20 January 2023Download -
Sai Life Sciences inks strategic agreement to set up Schrödinger’s first dedicated offshore Research Laboratories in India
10 January 2023Download -
SWIXX and Kyowa Kirin expand Partnership for Rare Disease Portfolio to 13 Countries in Europe
19 December 2022Download -
Mineralys Therapeutics Announces Positive Topline Phase 2 Data for MLS-101 in the Target-HTN Trial Evaluating the Treatment of Uncontrolled and Resistant Hypertension
16 November 2022Download -
Boditech Med and SphingoTec close global licensing agreement for kidney function biomarker Proenkephalin A 119-159 (penKid)
15 November 2022Download